文献速递胃肠外科围术期管理与 ERAS

机器人与腹腔镜胃癌根治术并发症严重程度与发生率:Clavien-Dindo分级回顾性倾向评分匹配研究

Severity and incidence of complications assessed by the Clavien-Dindo classification following robotic and laparoscopic gastrectomy for advanced gastric cancer: a retrospective and propensity score-matched study.
PubMed 文献 · Surg Endosc · 2018-12-17

匹配后RAG组总体并发症和严重并发症(C-D≥IIIa)发生率均显著低于LAG组。RAG在进展期胃癌D2淋巴结清扫中安全可行。

要点

  • RAG组总体并发症发生率24.5% vs LAG组18.8%,严重并发症8.9% vs 17.5%。
  • 年龄≥65岁、全胃切除、T3-T4a、II-III期、手术时间≥250min是总体并发症独立预测因素。
  • 年龄≥65岁、II-III期、手术时间≥250min是严重并发症独立危险因素。

核心结论

  • RAG联合D2淋巴结清扫治疗进展期胃癌安全可行,并发症发生率和严重程度低于LAG。

研究设计与样本

  • 采用Clavien-Dindo分级评估并发症,经1:1倾向评分匹配后分析446例(每组223例)。

主要发现

  • 匹配前RAG组肿瘤更小(P=0.004),既往腹部手术史更少(P=0.013)。
  • 匹配后RAG组总体并发症发生率显著低于LAG组(24.5% vs 18.8%,P<0.001)。
  • 匹配后RAG组严重并发症(C-D≥IIIa)发生率显著低于LAG组(8.9% vs 17.5%,P=0.002)。
  • 亚组分析在多数分层参数中亦显示显著差异。

关键数值与推荐

  • 总体并发症独立预测因素:年龄≥65岁、全胃切除、T3-T4a期、II-III期、手术时间≥250 min。
  • 严重并发症独立危险因素:年龄≥65岁、II-III期、手术时间≥250 min。

临床怎么用

  • 对于进展期胃癌需D2淋巴结清扫者,RAG可降低总体及严重并发症风险。
  • 关注年龄≥65岁、II-III期及手术时间≥250 min的高危患者,加强围术期管理。

局限性

  • 回顾性研究设计,存在选择偏倚可能,虽经倾向评分匹配但无法排除未测量混杂因素。
  • 单中心研究,结果外推需谨慎。
  • 样本量有限,亚组分析效能可能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted gastrectomy (RAG) has been increasingly used for the treatment of advanced gastric cancer (AGC), and many advantages over laparoscopy-assisted gastrectomy (LAG) have been reported. However, its postgastrectomy complications still under investigation and the results remain controversial. This study aimed to objectively assess the incidence and severity of complications following RAG vs. LAG using Clavien-Dindo (C-D) classification and to identify risk factors related to complications. METHODS: Five hundred and twenty-seven patients with AGC who underwent RAG or LAG between January 2016 and May 2018 were enrolled in this study. Complications were categorized according to the C-D classification. The complications following RAG and LAG were compared using one-to-one propensity score matching (PSM) analysis and subgroup analyses. Logistic regression analyses were performed to identify risk factors related to complications. RESULTS: RAG was performed in 251 patients (47.6%) and LAG in 276 patients (52.4%). Before PSM, the RAG group had a smaller tumour size (P = 0.004) and less patients with previous abdominal operation (P = 0.013). After PSM, a well-balanced cohort of 446 patients (223 in each group) was further analyzed. Of interest, the incidence of overall and severe complications (C-D grade ≥ IIIa) following the RAG group were significantly fewer than the LAG group (overall, 24.5% vs. 18.8%, P < 0.001; severe, 8.9% vs. 17.5%, P = 0.002). Subgroup analyses showed statistically significant difference were also observed in most stratified parameters. Multivariable analysis identified age ≥ 65 years, total gastrectomy, stage T3-T4a, stage II-III, and operation time ≥ 250 min as independent predictors of overall complications. Additionally, age ≥ 65 years, stage II-III, and operation time ≥ 250 min were confirmed as independent risk factors for severe complications. CONCLUSIONS: RAG with D2 lymphadenectomy is feasible and safe for the treatment of AGC in terms of the lower incidence and severity of complications.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Wang WJ, Li HT, Yu JP, et al. Severity and incidence of complications assessed by the Clavien-Dindo classification following robotic and laparoscopic gastrectomy for advanced gastric cancer: a retrospective and propensity score-matched study. Surg Endosc. 2018. PMID: 30560498. doi:10.1007/s00464-018-06624-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。